@article {147, title = {Cost-Efficiency of Medication Safety Program at Public Hospital, Riyadh, Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {September 2019}, pages = {S4-S8}, type = {Research Article}, chapter = {S4}, abstract = {

Objectives: Medication safety program started at Riyadh city of Ministry of Health in 2014. Identifying, resolving and preventing drug therapy problems are the unique contributions of the pharmaceutical care practitioner. The research aimed to estimate cost-efficiency of Medication Safety program at the hospital in East province, Saudi Arabia by using American model of pharmacist intervention cost avoidance. Methods: This cross-sectional study with a 9-month recruitment period was conducted in a 300-bed public hospital through preventing and documentation of medication errors in adults and pediatrics at Ministry of Health hospitals in 2015. The program led by trained pharmacist and delivered basic patient safety in medical education to all healthcare professionals. The predictable cost calculated using International Study Model, expressed in USD, the cost measured were the expected results of medication errors outcome if not stopped; starting from physician visit, additional laboratory test, further treatment, hospital admission and critical care admission to death stage. Results: The total number of prevented medication errors were 3,378 at 805 prescribed to 805 patients with an estimated cost avoidance of avoiding medication errors was (98,195.97 USD) for the study period and (10,910 USD) per month. The pharmacist avoided medication errors with estimated cost avoidance of drugrelated problem (29 USD) per each mistake and (122 USD) per prescription and patient. The most type inquiries estimated cost avoidance was prescribing stage 86,939.05 USD (99.86\%), followed by drugrelated errors 7,061.26 USD (7.2\%) and dosage form-related errors 6,084.98 USD (6.2\%). The highest drug of cost avoidance were Musculoskeletal and joint disease (8,397.2 USD) followed by Infections (5,731.17 USD) and Nutrition (4,717.99 USD), while the largest drug of cost avoidance was Paracetamol Injection (5,812.17 USD), followed by oral Ferrous Sulfate (3,562.79 USD) and Ceftriaxone 1g (2,861.70 USD). Conclusion: Medication safety program is a cost-efficiency simulation at the public hospital in Saudi Arabia, prevents medication disasters, improve patient safety. Increasing drug safety program associated with preventing drug-related problems and cost avoidance simulation for Healthcare development and better care and better patient consequences.

}, keywords = {Cost-efficiency, Hospital, Medication, Ministry of Health, Public, Riyadh, Safety, Saudi Arabia}, doi = {10.5530/PTB.2019.5.29}, author = {Yousef Ahmed Alomi and Mona Awad Alanazi and Radi Abdullah Alattyh and Fatimah Ali Albusalih} } @article {123, title = {Drug Evaluation Steps of Ministry of Health Drug Formulary in Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {January 2019}, pages = {8-15}, type = {Review Article}, chapter = {8}, abstract = {

Objective: To illustrate the Drug Evaluation Steps of Ministry of Health Drug Formulary at Health care institutions in the Kingdom of Saudi Arabia. Method: It is description analysis of Drug Evaluation Steps of drug information service at the Ministry of Health of Health institutions. The modified pharmacy business model system and Project Management Procedure used in the report. Results: The Drug Evaluation Steps established with a defined vision, mission and goals. The system human or economic and other resources described in the review. The risk management was discussed to assure the continuation of the system. Besides, the monitoring and controlling of the system as illustrated. The closing stage with convention to operation project demonstrated in the analysis. Conclusion: The drug evaluation steps system implemented and it is considered as part of the health care system and drug information centers regulations. The drug evaluation Steps needs the continuous updating accordingly at all Ministry of Health strategic planning in the Kingdom of Saudi Arabia.

}, keywords = {Drug Evaluation, Drug Formulary, Ministry of Health, Saudi Arabia, Steps}, doi = {10.5530/PTB.2019.5.3}, author = {Yousef Ahmed Alomi and Saeed Jamaan Alghamdi and Radi Abdullah Alattyh} } @article {117, title = {History and Strategies of Drug Information Services at Ministry of Health in Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {January 2019}, pages = {1-3}, type = {Review Article}, chapter = {1}, abstract = {

Over more thirty years back the first drug information services founded at Ministry of Health institutions in the Kingdom of Saudi Arabia. The drug information services stated with very simple and essential to the comprehensive with high quality and quantity specialized pharmacy practice. The services transferred over several periods from established time to advance stage and public stage. The drug information strategic plan founded for five years and included the updated Pharmacy strategic plan with Saudi vision 2030. The new drug information services started for the public with hotline at the Ministry of Health in the Kingdom of Saudi Arabia.

}, keywords = {Drug Information, History, Ministry of Health, Saudi Arabia, Services, Strategies}, doi = {10.5530/PTB.2019.5.1}, author = {Yousef Ahmed Alomi and Saeed Jamaan Alghamdi and Radi Abdullah Alattyh} } @article {104, title = {National Adverse Drug Reaction Reporting System at the Ministry of Health, Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {4}, year = {2018}, month = {September 2018}, pages = {21-23}, type = {Review Article}, chapter = {21}, abstract = {

Objective: To illustrate the adverse drug reaction during the pharmacy strategic plan at the Ministry of Health of Health institutions in the Kingdom of Saudi Arabia. Method: It is description analysis of adverse drug reaction system at the Ministry of Health of Health institutions. It was analysis within the Pharmacy strategic plan 2012-2020. The modified pharmacy business model system and Project Management Procedure used in the report. Results: The adverse drug reaction established with a defined vision, mission and goals. The system human or economic and other resources described in the review. The risk management was discussed to assure the continuation of the system. Besides, the monitoring and controlling of the system as illustrated. The closing stage with convention to operation project demonstrated in the Analysis. Conclusion: The Adverse drug reaction system implemented and it is considered as part of the healthcare system and pharmacy regulations. The documentation of ADR is updating improving accordingly at all Ministry of Health institutions in the Kingdom of Saudi Arabia

}, keywords = {Adverse drug reaction, Ministry of Health, Pharmaceutical Care, Saudi Arabia, System}, doi = {10.5530/PTB.2018.4.8}, author = {Yousef Ahmed Alomi and Saeed Jamaan Alghamdi and Radi Abdullah Alattyh} } @article {105, title = {National Corporate Pharmacy and Therapeutic Committee at the Ministry of Health, Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {4}, year = {2018}, month = {September 2018}, pages = {24-27}, type = {Review Article}, chapter = {24}, abstract = {

Objective: To review the Ministry of Health Corporate MOH Pharmacy and Therapeutic committee system at the Ministry of Health foundations in the Kingdom of Saudi Arabia. Method: It is a retrospective analysis of Ministry of Health Corporate MOH Pharmacy and Therapeutic committee system at Ministry of hospitals institutions. Its analysis illustrated within the Pharmacy strategic plan 2012-2020. The analysis process used. The modified pharmacy business model system and Project Management Procedure. Results: Ministry of Heath drug Corporate MOH Pharmacy and Therapeutic committee established with clear vision, mission and goals. The committee had human or economic and other resources described in the review. To assure the continuity of the system; the risk management was used and described. Besides, the monitoring and controlling of the system were demonstrated. The closing stage with convention to operation project shown in the Analysis. Conclusion: The Ministry of Health Corporate MOH Pharmacy and Therapeutic committee system founded though Pharmacy strategies and regulations. The Ministry of Health Corporate MOH Pharmacy and Therapeutic committee has regular development accordingly at all Ministry of Health hospitals and primary healthcare centers in the Kingdom of Saudi Arabia.

}, keywords = {Ministry of Health, Pharmacy and Therapeutic Committee, Saudi Arabia}, doi = {10.5530/PTB.2018.4.9}, author = {Yousef Ahmed Alomi and Saeed Jamaan Alghamdi and Radi Abdullah Alattyh} } @article {106, title = {National Drug Formulary of the Ministry of Health in Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {4}, year = {2018}, month = {September 2018}, pages = {28-30}, type = {Review Article}, chapter = {28}, abstract = {

Objective: To explore the Ministry of Health drug formulary system at the Ministry of Health foundations in the Kingdom of Saudi Arabia. Method: It is description analysis of Ministry of Health drug formulary system at Ministry of hospitals and primary healthcare centers. It analysis illustrated within the Pharmacy strategic plan 2012-2020. The analysis process used. The modified pharmacy business model system and Project Management Procedure. Results: Ministry of Heath drug formulary system established with clear vision, mission and goals. The project had human or economic and other resources described in the review. To assure the continuity of the system; the risk management was used and described. Besides, the monitoring and controlling of the system as illustrated. The closing stage with convention to operation project demonstrated in the Analysis. Conclusion: The Ministry of Heath drug formulary system founded and it is considered as part of Pharmacy strategic planning and regulations. The Ministry of Heath drug formulary has normal development accordingly at all Ministry of Health institutions in the Kingdom of Saudi Arabia.

}, keywords = {Drug, Formulary, Ministry of Health, Saudi Arabia}, doi = {10.5530/PTB.2018.4.10}, author = {Yousef Ahmed Alomi and Saeed Jamaan Alghamdi and Radi Abdullah Alattyh} } @article {107, title = {National Pharmacist Intervention Documentation System at the Ministry of Health in Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {4}, year = {2018}, month = {September 2018}, pages = {31-33}, type = {Review Article}, chapter = {31}, abstract = {

Objective: To review the pharmacist interventions documentation system at the Ministry of Health of Health hospitals and primary care centers in the Kingdom of Saudi Arabia. Method: It is description analysis of pharmacist interventions documentation system at the Ministry of Health of Health institutions. The system analyzed within the Pharmacy strategic plan 2012-2020. The modified pharmacy business model system and Project Management Procedure used in the analysis. Results: Pharmacist intervention documentation system founded with a clear vision, mission and goals. The project had human or economic and other resources clarified in the review. The risk management was described to assure the continuation of the system. Besides, the monitoring and controlling of the system as illustrated. The closing project stage with convention to operation project demonstrated in the Analysis. Conclusion: The Pharmacist interventions documentation system founded and it is considered as part of Pharmacy administration regulations. The documentation of pharmacist interventions has normal development accordingly at all Ministry of Health institutions in the Kingdom of Saudi Arabia.

}, keywords = {Ministry of Health, Pharmaceutical Care, Pharmacist Intervention, Saudi Arabia}, doi = {10.5530/PTB.2018.4.11}, author = {Yousef Ahmed Alomi and Saeed Jamaan Alghamdi and Radi Abdullah Alattyh} } @article {108, title = {On-the-Job Training of Pharmacy Technicians at the Ministry of Health Hospitals in Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {4}, year = {2018}, month = {September 2018}, pages = {34-36}, type = {Review Article}, chapter = {34}, abstract = {

Objective: To demonstrate the pharmacy technicians on the job training at the Ministry of Health of Health hospitals in the Kingdom of Saudi Arabia. Method: It is a retrospective analysis of pharmacy technicians on job training project at the Ministry of Health of Health hospitals. It was within The Pharmacy strategic plan 2012-2020. The study used the modified pharmacy business model system and Project Management Procedure. Results: The pharmacy technicians on job training system established with a defined vision, mission and goals. The system had several resources including human or economic and other described in the review. The continuation of the system assured by risk management model description. Also, the monitoring and controlling of the system as illustrated. The convention to operation project though closing project stage demonstrated in the Analysis. Conclusion: The pharmacy technicians on job training system established within the healthcare system and pharmacy regulations. The pharmacy technicians on the job training system are regularly improving accordingly at all Ministry of Health hospitals in the Kingdom of Saudi Arabia.

}, keywords = {Job, Ministry of Health, Pharmacy Technicians, Saudi Arabia, Training}, doi = {10.5530/PTB.2018.4.12}, author = {Yousef Ahmed Alomi and Saeed Jamaan Alghamdi and Radi Abdullah Alattyh} }